Piperidine derivative and pharmaceutical composition containing the same
    1.
    发明授权
    Piperidine derivative and pharmaceutical composition containing the same 失效
    哌啶衍生物和含有其的药物组合物

    公开(公告)号:US5179095A

    公开(公告)日:1993-01-12

    申请号:US798963

    申请日:1991-11-26

    摘要: A new piperidine compound is pharmacologically effective for treatment of the arrythmia and is defined by the formula: ##STR1## in which R.sup.1 is a lower alkyl or a tolyl, R.sup.2 is hydrogen, hydroxyl, a lower alkoxy or a lower alkyl, R.sup.3 is hydrogen, a lower alkyl, a lower alkenyl, a cycloalkyl or a cycloalkylalkyl, X is --CO--, --CH.sup.2 -- or --CHOH--, g is an integer of 1 to 3, h is an integer of 1 to 3, Y is hydrogen, a lower alkyl, a lower alkenyl, cyano, CH.sup.2 COOR, R being hydrogen or a lower alkyl, a cycloalkyl, a cycloalkylalkyl, ##STR2## 1 being 1 or 2, --A--B, A being --(CH.sub.2).sub.n --, n being an integer of 1 to 5,a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkane having lower alkyl, phenyl or hydroxyl group(s) bonded directly to one or more carbon atoms constituting said alkane by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof,a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkene having a double bond formed between carbon atoms adjacent to each other by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof,--(CH.sub.2)k--S--, k being an integer of 2 to 5, --(CH.sub.2)p--CO--, p being an integer of 1 to 4, B being cyano, --NR.sub.4 R.sub.5, a heterocyclic ring or a condensed aromatic ring.

    摘要翻译: 新的哌啶化合物在治疗心律失常方面是药理学有效的,并由下式定义:其中R1是低级烷基或甲苯基,R2是氢,羟基,低级烷氧基或低级烷基,R3是氢 低级烷基,低级烯基,环烷基或环烷基烷基,X为-CO-,-CH 2 - 或-CHOH-,g为1〜3的整数,h为1〜3的整数,Y为氢 ,低级烷基,低级烯基,氰基,CH 2 COOR,R为氢或低级烷基,环烷基,环烷基烷基,A为1或2,-AB,A为 - (CH 2)n - ,n为 1至5的整数,具有1至5个碳原子的直链亚烷基,其是衍生自直接与一个或多个碳原子键合的低级烷基,苯基或羟基的直链烷烃的二价基团 通过除去与位于其两端的每个碳原子键合的氢原子构成所述烷烃,具有1至5个碳原子的直链亚烷基,其是 通过除去与位于其两端的每个碳原子键合的氢原子,通过除去彼此相邻的碳原子之间形成的双键的直链烯烃的二价基团, - (CH 2)k S - ,k为 2〜5的整数, - (CH 2)p -CO-,p为1〜4的整数,B为氰基,-NR 4 R 5,杂环或稠合芳环。

    1-(N-Substituted carbamoyl)-5-fluorouracil derivatives and the
carcinostatic agents containing same as active ingredients
    10.
    发明授权
    1-(N-Substituted carbamoyl)-5-fluorouracil derivatives and the carcinostatic agents containing same as active ingredients 失效
    1-(N-取代的氨基甲酰基)-5-氟尿嘧啶衍生物和含有活性成分的制癌剂

    公开(公告)号:US4497815A

    公开(公告)日:1985-02-05

    申请号:US455863

    申请日:1983-01-05

    CPC分类号: C07D239/553

    摘要: A 1-(N-substituted carbamoyl)-5-fluorouracil derivative represented by the following general formula: ##STR1## R is a 4-alkoxycyclohexyl group-containing radical which is 2,3,4-trimethoxycyclohexcylethyl, 2,3,4-trimethoxycyclohexyl, 2,4-dimethoxycyclohexylmethyl, 3,4-dimethoxycyclohexylethyl, 2,4-dimethoxycyclohexyl, 2,4,5-trimethoxycyclohexyl, 3,4-dimethoxycyclohexylmethyl, 3,4,5-trimethoxycyclohexyl, 4-ethoxycyclohexyl or 4-ethoxycyclohexylmethyl. The compounds are carcinostatic agents. The compounds are used in a therapeutically effective amount in the presence of a carrier.

    摘要翻译: 由以下通式表示的1-(N-取代氨基甲酰基)-5-氟尿嘧啶衍生物:(1)R是含4-烷氧基环己基的基团,它是2,3,4-三甲氧基环己基乙基,2,3 ,4-三甲氧基环己基,2,4-二甲氧基环己基甲基,3,4-二甲氧基环己基乙基,2,4-二甲氧基环己基,2,4,5-三甲氧基环己基,3,4-二甲氧基环己基甲基,3,4,5-三甲氧基环己基,4-乙氧基环己基或4 乙氧基环己基甲基。 化合物是制癌剂。 化合物在载体存在下以治疗有效量使用。